Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

04. November 2015 07:00 ET | Quelle: Akers Biosciences Inc.

Akers Biosciences' Flagship Test for Heparin-Induced Thrombocytopenia Granted Approval by Chinese Food and Drug Administration

THOROFARE, N.J., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of healthcare...
14. September 2015 07:00 ET | Quelle: Akers Biosciences Inc.

Akers Biosciences Launches METRON(R) - the First and Only Disposable Breath Ketone Test

THOROFARE, N.J., Sept. 14, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of...
06. Mai 2015 07:00 ET | Quelle: Akers Biosciences Inc.

Akers Biosciences Signs Agreement to Sell METRON(R) Breath Ketone Test Online, With Key Focus on Amazon Marketplace

THOROFARE, N.J., May 6, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of healthcare...